Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation

Wei-Hua ZHAI; Qing-Zhen LIU; Yuan-Yuan SHI; Gang LI; Jia-Li SUN; Xin CHEN; Jian-Feng YAO; Xiu-Hua SU; Qiao-Ling MA; Ai-Ming PANG; Yi HE; Dong-Lin YANG; Rong-Li ZHANG; Yong HUANG; Jia-Lin WEI; Si-Zhou FENG; Ming-Zhe HAN; Er-Lie JIANG.
Chinese Journal of Hematology ; (12): 932-936, 2018.
Artículo en Zh | WPRIM | ID: wpr-1011891

Documentos relacionados

  1. [Prognostic significance of early phase donor chimerism after allogeneic peripheral blood stem cell transplantation].
  2. Immune reconstitution and survival of patients after allogeneic hematopoietic stem cell transplantation from older donors.
  3. [Establishment of acute graft-versus-host disease model after non-myeloablative haploidentical peripheral blood stem cell transplantation in aged mice].
  4. Impact of CD34 positive cell dose in donor graft on the outcomes after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide - A retrospective single-center study with a Japanese cohort.
  5. Epidemiology and clinical profiles of cutaneous graft versus host disease in allogeneic peripheral blood stem cell transplantation.
  6. Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age.
  7. A Clinic Study on Long-term Efficacy and Safety of Autologous Peripheral Blood Stem Cell Transplantation in Patients with Decompensated Hepatitis B Cirrhosis.
  8. Primed for change: The effect of a blood prime on peripheral blood stem cell collection and accuracy of a prediction tool in pediatric patients.
  9. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
  10. Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group.